• 1
    Medzithov R., Janway Jr.C.A. (1997) Innate immunity: The virtues of a nonclonal system of recognition. Cell 91: 2958.
  • 2
    Akira S., Takeda K, Kaisho T. (2001) Toll-like receptors: critical proteins linking innate and acquired immunity. Nat Immunol 2: 67580.
  • 3
    Tominaga A, Okuyama H., Fukuoka S., Taguchi T., Kusumoto Y., Shimizu K., Ono S. (2010) Effects of edible algae polysaccharides on allergic, inflammatory, and anti-tumor responses through toll-like receptor 4. Anti-Inflamm Anti-Allergy Agents Med Chem 9: 23850.
  • 4
    Belay A. (2008) Spirulina (Arthrospira): Production and quality assurance. In: Gershwin M.E., Belay A., eds. Spirulina in human nutrition and health. New York: CRC Press, pp. 125.
  • 5
    Tornabene T., Bourne T., Raziuddin S., Ben-Amotz A. (1985) Lipid and lipopolysaccharide constituents of cyanobacterium Spirulina platensis (Cyanophyceae, Nostocales). Mar Ecol 22: 1215.
  • 6
    Poltorak A., Xiaolong He., Smirnova I., Liu Mu-Ya., Van Huffel C., Du X., Birdwell D., Alejos E., Silva M., Galanos C., Freudenberg M., Ricciardi-Castagnoli P., Layton B., Beutler B. (1998) Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: Mutations in Tlr4 gene. Science 282: 20858.
  • 7
    Mosmann T.R., Coffman R.L., (1989) TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 7: 14573.
  • 8
    Dong C. (2008) TH17 cells in development: an updated view of their molecular identity and genetic programming. Nat Rev Immunol 8: 33748.
  • 9
    Weaver C.T., Hatton R.D., Mangan P.R., Harrington L.E. (2007) IL-17 family cytokines and the expanding diversity of effector T cell lineages. Annu Rev Immunol 25: 82152.
  • 10
    Kastelein R.A., Hunter C.A., Cua D.J. (2007) Discovery and biology of IL-23 and IL-27: related but functionally distinct regulators in inflammation. Annu Rev Immunol 25: 22142.
  • 11
    Korn T., Bettelli E., Oukka M., Kuchroo V.K. (2009) IL-17 and Th17 cells. Annu Rev Immunol 27: 485517.
  • 12
    Grauer O.M., Molling J.W., Bennink E., Toonen L.W.J., Sutmukker R.P.M., Nierkens S., Adema G.J. (2008) TLR ligands in the local treatment of established intracerebral murine gliomas. J Immunol 181: 67209.
  • 13
    Chicoine M.R., Zahner M., Won E.K., Karla R.R., Kitamura T., Perry A., Higashikubo R. (2007) The in vivo anti-tumoral effects of lipopolysaccharide against glioblastoma multiforme are mediated in part by toll-like receptor 4. Neurosurgery 60: 37280.
  • 14
    Mizuno D-.I., Yoshioka O., Akamatu M., Kataoka T. (1968) Anti-tumor effect of intracutaneous injection of bacterial lipopolysaccharide. Cancer Res 28: 15317.
  • 15
    Ohnishi M., Kimura S., Yamazaki M., Oshima H., Mizuno D-.I., Abe S., Yamaguchi H. (1994) Anti-tumor activity of low-toxicity lipopolysaccharide of Bordetella pertussis. Br J Cancer 69: 103842.
  • 16
    Westphal O., Jann K. (1965) Bacterial lipopolysaccharides. Extraction with phenol-water and further applications of the procedure. Methods in Carbohydrate Chemistry 5: 8391.
  • 17
    Kumanishi T., Ikuta F., Yamamoto T. (1973) Brain tumors by Rous sarcoma virus, Schmidt-Ruppin strain. III. Morphology of brain tumors induced in adult mice. J Natl Cancer Inst 50: 95109.
  • 18
    Numasaki M., Fukushi J-.I., Ono M., Narula S.K., Zavondny P.J., Kudo T., Robbins P.D., Tahara H., Lotze M.T. (2003) Interleukin-17 promotes angiogenesis and tumor growth. Blood 101: 262027.
  • 19
    Rahman R., Smith S., Rahman C., Grundy R. (2010) Antiangiogenic therapy and mechanisms of resistance in malignant glioma. J Oncology, Article ID 251231, doi: 10.1155/2010/251231.
  • 20
    Tartour E., Fossiez F., Joyeux I., Galinha A., Gey A., Claret E., Sastre-Garau X., Couturier J., Mosseri V., Vives V., Banchereau J., Fridman W.H., Wijdenes J., Lebecque S., Sautès-Fridman C. (1999) Interleukin 17, a T-cell-derived cytokine, promotes tumorigenicity of human cervical tumors in nude mice. Cancer Res 59: 3698704.
  • 21
    Benchetrit F., Ciree A., Vives V., Warnier G., Gey A., Sautès-Fridman C., Fossiez F., Haicheur N., Fridman W.H., Tartour E. (2002) Interleukin-17 inhibits tumor cell growth by means of a T-cell-dependent mechanism. Blood 99: 211421.
  • 22
    Martin-Orozco N., Muranski P., Chung Y., Yang X.O., Yamazaki T., Lu S., Hwu P., Restifo N.P., Overwijk W.W., Dong C. (2009) T helper 17 cells promote cytotoxic T cell activation in tumor immunity. Immunity 31: 78798.
  • 23
    Langowski J.L., Zhang X., Wu L., Mattson J.D., Chen T., Smith C., McClanahan T., Kastelein R.A., Oft M. (2006) IL-23 promotes tumour incidence and growth. Nature 442: 4615.
  • 24
    Akashi S., Saitoh S-.I., Wakabayashi Y., Kikuchi T., Takamura N., Nagai Y., Kusumoto Y., Fukase K., Kusumoto S., Adachi Y., Kosugi A., Miyake K. (2003) Lipopolysaccharide interaction with cell surface toll-like receptor 4-MD-2: higher affinity than that with MD-2 or CD14. J Exp Med 198: 103542.
  • 25
    Morrison D.C., Jacobs D.M. (1976) Binding of polymyxin B to the lipid A portion of bacterial lipopolysaccharides. Immunochemistry 13: 8138.
  • 26
    Darveau R.P., Pham T-.T.T., Lemley K., Reife R.A., Bainbridge B.W., Coats S.R., Howald W.N., Way S.S., Hajjar A.M. (2004) Porphyromonas gingivalis lipopolysaccharide contains multiple lipid A species that functionally interact with both toll-like receptors 2 and 4. Infection and Immunity 72: 504151.
  • 27
    Mishima T., Murata J., Toyoshima M., Fujii H., Nakajima M., Hayashi T., Kato T., Saiki I. (1998) Inhibition of tumor invasion and metastasis by calcium spirulan (Ca-SP), a novel sulfated polysaccharide derived from a blue-green alga, Spirulina platensis. Clin Exp Metastasis 16: 54150.
  • 28
    Balachandran P., Pugh N.D., Ma G., Pasco D.S. (2006) Toll-like receptor 2-dependent activation of monocytes by Spirulina polysaccharide and its immune enhancing action in mice. Int Immunopharmacol 6: 180814.
  • 29
    Akao Y., Ebihara T., Masuda H., Saeki Y., Akazawa T., Hazeki O., Matsumoto M., Seya T. (2009) Enhancement of antitumor natural killer cell activation by orally administered Spirulina extract in mice. Cancer Sci 100: 1494501.
  • 30
    Dalton D.K., Pitts-Meek S., Keshav S., Figari I.S., Bradley A., Stewart T.A. (1993) Multiple defects of immune cell function in mice with disrupted interferon-γ genes. Science 259: 173942.
  • 31
    Shankaran V., Ikeda H., Bruce A.T., White J.M., Swanson P.E., Old L.J., Schreiber R.D. (2001) IFNγ and lymphocytes prevent primary tumour development and shape tumour immunogenicity. Nature 410: 110711.